Prevalence of smoking among psychiatric outpatients

Back to table of contents Previous article Next article No AccessPrevalence of smoking among psychiatric outpatientsPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.143.8.993AboutSectionsView articleAbstractPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleAbstractThe prevalence of smoking among psychiatric outpatients (N = 277) was significantly higher than among either local or national population- based samples (N = 1,440 and 17,000) (52% versus 30% and 33%). The higher prevalence was not associated with the age, sex, marital status, socioeconomic status, alcohol use, coffee use, or institutionalization of the psychiatric patients. Smoking was especially prevalent among patients with schizophrenia (88%) or mania (70%) and among the more severely ill patients. Hypotheses about why psychiatric patients are more likely to smoke and why they do not have a high rate of smoking- induced illnesses are presented. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byNicotine pretreatment alleviates MK-801-induced behavioral and cognitive deficits in mice by regulating Pdlim5/CRTC1 in the PFC29 August 2022 | Acta Pharmacologica Sinica, Vol. 76Impact of Nicotine on Cognition in Patients With Schizophrenia: A Narrative ReviewCureus, Vol. 27Neurophysiology of Basic Molecules Affecting Sleep and Wakefulness Mechanisms, Fundamentals of Sleep Pharmacology7 January 2022Molecular mechanisms underlying cannabis-induced risk of psychosisSmoking in Psychiatric Patients: Need for a Concerted Approach13 October 2021 | Eastern Journal of Psychiatry, Vol. 17, No. 1Addiction and the kynurenine pathway: A new dancing couple?Pharmacology & Therapeutics, Vol. 223Prevalence and Determinants of Mental Health among COPD Patients in a Population-Based Sample in Spain24 June 2021 | Journal of Clinical Medicine, Vol. 10, No. 13Antipsychotic Agents26 April 2021Exploring the impact of adolescent exposure to cannabinoids and nicotine on psychiatric risk: insights from translational animal models5 December 2019 | Psychological Medicine, Vol. 51, No. 6Cognitive function in women with major mental illnesses who use tobaccoPsychiatry Research, Vol. 295ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder1 September 2020 | American Journal of Health-System Pharmacy, Vol. 77, No. 24The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal31 May 2020 | Journal of Neuroscience Research, Vol. 98, No. 8Smoking and Mental Illness: Prevalence, Patterns and Correlates of Smoking and Smoking Cessation among Psychiatric Patients1 August 2020 | International Journal of Environmental Research and Public Health, Vol. 17, No. 15Drug instrumentalizationBehavioural Brain Research, Vol. 390Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients3 February 2020 | Neuropsychopharmacology, Vol. 45, No. 8Muscarinic M1 Receptors Modulate Working Memory Performance and Activity via KCNQ Potassium Channels in the Primate Prefrontal CortexNeuron, Vol. 106, No. 4Non-pharmacological factors that determine drug use and addictionNeuroscience & Biobehavioral Reviews, Vol. 110Smoking Prevalence, Nicotine Dependence, and Impulsivity in Obsessive-Compulsive Disorder11 June 2018 | International Journal of Mental Health and Addiction, Vol. 18, No. 1Cholinergic Receptors and Addiction26 May 2020Involvement of Nicotinic Receptors in Working Memory Function26 May 2020ReferencesSmoking in schizophreniaCurrent Opinion in Psychiatry, Vol. 32, No. 5Association between smoking, and hospital readmission among inpatients with psychiatric illness at an academic inpatient psychiatric facility, 2000–2015Addictive Behaviors Reports, Vol. 9The effects of oral nicotine administration and abstinence on sleep in male C57BL/6J mice18 December 2018 | Psychopharmacology, Vol. 236, No. 4Cochrane Database of Systematic ReviewsAsian Journal of Psychiatry, Vol. 43Mental Illness, Vol. 11, No. 2Addiction Biology, Vol. 24, No. 4Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study17 January 2018 | Journal of Psychopharmacology, Vol. 32, No. 5Management of Common Medical Conditions by Office-Based PsychiatristsRamin Mojtabai, M.D., Ph.D., and Mark Olfson, M.D., M.P.H.1 December 2017 | Psychiatric Services, Vol. 69, No. 4Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophreniaSchizophrenia Research, Vol. 194Life Sciences, Vol. 194Journal of Addiction, Vol. 2018Korean Journal of Schizophrenia Research, Vol. 21, No. 1Konuralp Tıp DergisiCurrent Drug Targets, Vol. 20, No. 2Frontiers in Neural Circuits, Vol. 12Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain13 July 2017 | Journal of Medical Economics, Vol. 20, No. 10Genetic Basis of Positive and Negative Symptom Domains in Schizophrenia10 July 2017 | Biological Research For Nursing, Vol. 19, No. 5CNS Drugs, Vol. 31, No. 5Psychoneuroendocrinology, Vol. 81Scientific Reports, Vol. 7, No. 1Attenuated Positive Psychotic Symptoms in Relation to Cigarette Smoking in a Nonclinical Population20 September 2016 | Nicotine & Tobacco Research, Vol. 19, No. 1Nicotine & Tobacco Research, Vol. 19, No. 5Annals of the New York Academy of Sciences, Vol. 1408, No. 1Journal of Evolution of Medical and Dental Sciences, Vol. 6, No. 45Clinical Schizophrenia & Related Psychoses, Vol. 11, No. 1The effects of cigarette smoking behavior and psychosis history on general and social cognition in bipolar disorder21 September 2016 | Bipolar Disorders, Vol. 18, No. 6BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment4 May 2016 | Journal of Psychopharmacology, Vol. 30, No. 8Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonistsEuropean Journal of Medicinal Chemistry, Vol. 115Epidemiology of Cardiovascular Disease and Depression2 August 2016Nicotine Dependence and SchizophreniaInternet Interventions, Vol. 4Schizophrenia Research, Vol. 176, No. 2-3Nicotine & Tobacco Research, Vol. 18, No. 6Acta Psychiatrica Scandinavica, Vol. 133, No. 6Perspectives in Psychiatric Care, Vol. 52, No. 1The Japanese Journal of Health Psychology, Vol. 28, No. Special_issueKorean Journal of Health Education and Promotion, Vol. 33, No. 1Enforced abstinence from tobacco during in‐patient dual‐diagnosis treatment improves substance abuse treatment outcomes in smokers23 April 2015 | The American Journal on Addictions, Vol. 24, No. 3Substance‐Related and Addictive Disorders: Tobacco‐Related Disorders20 February 2015European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, No. 3Current Addiction Reports, Vol. 2, No. 1, Vol. 124Behavioural Brain Research, Vol. 291Biochemical Pharmacology, Vol. 97, No. 4Acta Psychiatrica Scandinavica, Vol. 131, No. 3Bipolar Disorders, Vol. 17, No. 6Psychopathology and the Ability to Do Otherwise8 April 2013 | Philosophy and Phenomenological Research, Vol. 90, No. 1BioMed Research International, Vol. 2015BMC Medical Genetics, Vol. 16, No. 1Predictors of Tobacco Use Among New York State Addiction Treatment PatientsAmerican Journal of Public Health, Vol. 105, No. 1Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study19 March 2014 | Annals of General Psychiatry, Vol. 13, No. 1EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness30 January 2014 | European Psychiatry, Vol. 29, No. 2, Vol. 13American Journal of Preventive Medicine, Vol. 46, No. 3Behavioural Brain Research, Vol. 275General Hospital Psychiatry, Vol. 36, No. 3Psychiatry Research, Vol. 215, No. 2Molecular Psychiatry, Vol. 19, No. 4Nature, Vol. 511, No. 7510Translational Psychiatry, Vol. 4, No. 6Journal of Dual Diagnosis, Vol. 10, No. 4Nicotine & Tobacco Research, Vol. 16, No. 11Annals of the New York Academy of SciencesClinical Schizophrenia & Related Psychoses, No. aopSynthesis of 1-substituted epibatidine analogues and their in vitro and in vivo evaluation as α 4 β 2 nicotinic acetylcholine receptor ligands1 January 2014 | RSC Advances, Vol. 4, No. 5Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate releaseNeuroscience, Vol. 255Smokers With Behavioral Health Comorbidity Should Be Designated a Tobacco Use Disparity GroupAmerican Journal of Public Health, Vol. 103, No. 9Tobacco Smoking in Adolescent Psychiatric Outpatients22 March 2013 | Journal of Child & Adolescent Substance Abuse, Vol. 22, No. 3Varenicline Treatment of Concurrent Alcohol and Nicotine Dependence in SchizophreniaJournal of Clinical Psychopharmacology, Vol. 33, No. 2Associations of Mental Health Problems With Waterpipe Tobacco and Cigarette Smoking Among College Students10 January 2013 | Substance Use & Misuse, Vol. 48, No. 3Brain and Behavior, Vol. 3, No. 4Depression and AnxietyDepression and Anxiety, Vol. 30, No. 6Psychopharmacology, Vol. 229, No. 3Metabolic Brain Disease, Vol. 28, No. 3Neurotoxicity Research, Vol. 24, No. 2Brain Research Bulletin, Vol. 93Drug and Alcohol Dependence, Vol. 133, No. 2Journal of Psychiatric Research, Vol. 47, No. 7Journal of Psychiatric Research, Vol. 47, No. 11Neuroscience & Biobehavioral Reviews, Vol. 37, No. 9Psychiatry Research, Vol. 205, No. 3Psychiatry Research, Vol. 210, No. 1Neuropsychopharmacology, Vol. 38, No. 6Substance Abuse, Vol. 34, No. 2Journal of Dual Diagnosis, Vol. 9, No. 1Journal of Dual Diagnosis, Vol. 9, No. 1Nicotine & Tobacco Research, Vol. 15, No. 1Genes, Brain and Behavior, Vol. 12, No. 4The American Journal on Addictions, Vol. 22, No. 2The American Journal on Addictions, Vol. 22, No. 1Expert Opinion on Investigational Drugs, Vol. 22, No. 2BibliographiePersistent β2*-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive DisorderAybala Saricicek, M.D., Irina Esterlis, Ph.D., Kathleen H. Maloney, B.A., Yann S. Mineur, Ph.D., Barbara M. Ruf, B.A., Anjana Muralidharan, B.A., Jason I. Chen, B.A., Kelly P. Cosgrove, Ph.D., Rebecca Kerestes, Ph.D., Subroto Ghose, M.D., Ph.D., Carol A. Tamminga, M.D., Brian Pittman, M.S., Frederic Bois, Ph.D., Gilles Tamagnan, Ph.D., John Seibyl, M.D., Marina R. Picciotto, Ph.D., Julie K. Staley, Ph.D., and Zubin Bhagwagar, M.D., Ph.D., M.R.C.Psych.1 August 2012 | American Journal of Psychiatry, Vol. 169, No. 8Unusual Effects of Nicotine as a Psychostimulant on Ambulatory Activity in MiceISRN Pharmacology, Vol. 2012The role of the α7 nicotinic receptor in cognitive processing of persons with schizophreniaCurrent Opinion in Psychiatry, Vol. 25, No. 2, Vol. 213Social Psychiatry and Psychiatric Epidemiology, Vol. 47, No. 11Human Genetics, Vol. 131, No. 6Indian Journal of Clinical Biochemistry, Vol. 27, No. 3Revista Colombiana de Psiquiatría, Vol. 41, No. 2Comprehensive Psychiatry, Vol. 53, No. 3Neuroscience & Biobehavioral Reviews, Vol. 36, No. 5Neuropharmacology, Vol. 62, No. 3Neuropharmacology, Vol. 62, No. 3Neuroscience, Vol. 216Pharmacology Biochemistry and Behavior, Vol. 100, No. 3Psychiatry Research: Neuroimaging, Vol. 201, No. 2Respiratory Medicine, Vol. 106, No. 7Schizophrenia Research, Vol. 139, No. 1-3Schizophrenia Research, Vol. 141, No. 1Journal of Smoking Cessation, Vol. 7, No. 1Neuropsychopharmacology, Vol. 37, No. 5AJOB Neuroscience, Vol. 3, No. 2Nicotine & Tobacco Research, Vol. 14, No. 11Schizophrenia Bulletin, Vol. 38, No. 3Bipolar Disorders, Vol. 14, No. 6BMC Medicine, Vol. 10, No. 1Substance Abuse Treatment, Prevention, and Policy, Vol. 7, No. 1Journal of Neurodevelopmental Disorders, Vol. 4, No. 1The Korean Journal of Health Service Management, Vol. 6, No. 1Journal of Behavioral Addictions, Vol. 1, No. 4Nordic Journal of Psychiatry, Vol. 66, No. 4Open Journal of Psychiatry, Vol. 02, No. 04International Journal of High Risk Behaviors and Addiction, Vol. 1, No. 2Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking statusPsychiatry Research, Vol. 188, No. 3Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment24 August 2010 | Journal of Clinical Pharmacy and Therapeutics, Vol. 36, No. 4Relationship between Smoking and Family History of Smoking in Schizophrenia Patients14 April 2011 | The International Journal of Psychiatry in Medicine, Vol. 41, No. 2, Vol. 1Psychopharmacology, Vol. 216, No. 1Community Mental Health Journal, Vol. 47, No. 6Maternal and Child Health Journal, Vol. 15, No. 5Medicine - Programa de Formación Médica Continuada Acreditado, Vol. 10, No. 86Biological Psychiatry, Vol. 69, No. 1Journal of Psychiatric Research, Vol. 45, No. 12Psychiatry Research, Vol. 186, No. 2-3Psychiatry Research, Vol. 190, No. 1Psychiatry Research, Vol. 190, No. 2-3Behavioral and Brain Sciences, Vol. 34, No. 6Aging & Mental Health, Vol. 15, No. 1Antioxidants & Redox Signaling, Vol. 15, No. 7Nicotine & Tobacco Research, Vol. 13, No. 12Bipolar Disorders, Vol. 13, No. 5-6Respirology, Vol. 16, No. 7Genes, Brain and Behavior, Vol. 10, No. 5BMC Psychiatry, Vol. 11, No. 1Overlap of genetic influences in phenotypes classically categorized as psychiatric vs medical disordersWorld Journal of Medical Genetics, Vol. 1, No. 1The Impact of Smoking on Clinical Outcomes After First Episode Psychosis: Longer-Term Outcome Findings From the EPPIC 800 Follow-Up StudyJournal of Dual Diagnosis, Vol. 6, No. 3-4Behavioural and Psychological Mechanisms Linking Depression and Heart Disease14 November 2010Carbamazepine but Not Valproate Induces CYP2A6 Activity in Smokers with Mental Illness6 October 2010 | Cancer Epidemiology, Biomarkers & Prevention, Vol. 19, No. 10Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 12, No. 3Comorbidity in Bipolar Disorder: A Focus on Addiction and Anxiety Disorders13 August 2010A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction19 July 2010 | Proceedings of the National Academy of Sciences, Vol. 107, No. 30Depression in patients with heart disease: the case for more trialsFuture Cardiology, Vol. 6, No. 4Nicotinic modulation of attentional deficits in schizophreniaCigarette Smoking in Patients with Schizophrenia in China: Prospective, Multicentre Study1 May 2010 | Australian & New Zealand Journal of Psychiatry, Vol. 44, No. 5Smoking, nicotine and neuropsychiatric disordersNeuroscience & Biobehavioral Reviews, Vol. 34, No. 3Lung, Vol. 188, No. 5Revista Médica Clínica Las Condes, Vol. 21, No. 5Biological Psychiatry, Vol. 68, No. 7Journal of Substance Abuse Treatment, Vol. 38, No. 4Schizophrenia Research, Vol. 119, No. 1-3Schizophrenia Research, Vol. 123, No. 2-3Nicotine & Tobacco Research, Vol. 12, No. 5Schizophrenia Bulletin, Vol. 36, No. 1Genes, Brain and Behavior, Vol. 9, No. 8The Journal of Clinical Pharmacology, Vol. 50, No. 1BMC Medical Genetics, Vol. 11, No. 1BMC Psychiatry, Vol. 10, No. 1Suicide and Life-Threatening Behavior, Vol. 40, No. 4Jornal Brasileiro de Pneumologia, Vol. 36, No. 1Journal of the Korean Society for Research on Nicotine and Tobacco, Vol. 1, No. 2Addiction Research & Theory, Vol. 18, No. 6Mechanisms Underlying the Comorbidity of Tobacco Use in Mental Health and Addictive Disorders1 June 2009 | The Canadian Journal of Psychiatry, Vol. 54, No. 6Varenicline reduced smoking behaviour in a mentally ill person18 June 2008 | Journal of Psychopharmacology, Vol. 23, No. 3Tobacco Abuse: Treatment and Management18 March 2011Citation Bias in Reported Smoking Prevalence in People with Schizophrenia1 January 2009 | Australian & New Zealand Journal of Psychiatry, Vol. 43, No. 3Windows of Opportunity for Culture Change Around Tobacco Use in Mental Health Settings1 February 2009 | Journal of the American Psychiatric Nurses Association, Vol. 15, No. 1Psychopharmacology, Vol. 202, No. 1-3Effects of Smoking on Hormones, Brain, and BehaviorThe Joint Commission Journal on Quality and Patient Safety, Vol. 35, No. 11Addictive Behaviors, Vol. 34, No. 3Addictive Behaviors, Vol. 34, No. 6-7Drug and Alcohol Dependence, Vol. 100, No. 1-2Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial16 April 2020 | European Psychiatry, Vol. 24, No. 1Medical Hypotheses, Vol. 73, No. 2Pharmacology Biochemistry and Behavior, Vol. 92, No. 1Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 33, No. 2Schizophrenia Research, Vol. 107, No. 2-3American Journal of Psychiatric Rehabilitation, Vol. 12, No. 4Journal of Dual Diagnosis, Vol. 5, No. 2Journal of Dual Diagnosis, Vol. 5, No. 2Mental Health and Substance Use, Vol. 2, No. 1Schizophrenia Bulletin, Vol. 35, No. 4Perspectives in Psychiatric Care, Vol. 38, No. 2Cigarette Smoking, Nicotine Dependence, and Motivation for Smoking Cessation in Psychiatric Inpatients1 January 2009 | The Canadian Journal of Psychiatry, Vol. 54, No. 1BMC Public Health, Vol. 9, No. 1Expert Opinion on Therapeutic Targets, Vol. 13, No. 4Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified miceBehavioural Pharmacology, Vol. 19, No. 5-6Correspondence1 January 2008 | Australian & New Zealand Journal of Psychiatry, Vol. 42, No. 7El tabaquismo relacionado con la ansiedad y la depresión: evidencias de una encuesta de población: estudio HUNT12 May 2020 | European psychiatry (Ed. Española), Vol. 15, No. 5Smoking in relation to anxiety and depression: Evidence from a large population survey: The HUNT study16 April 2020 | European Psychiatry, Vol. 23, No. 2The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls18 April 2007 | Neuropsychopharmacology, Vol. 33, No. 3Social Psychiatry and Psychiatric Epidemiology, Vol. 43, No. 6Psychopharmacology, Vol. 199, No. 1Journal of Neural Transmission, Vol. 115, No. 10Molecular Neurobiology, Vol. 38, No. 1Chronic Mental IllnessAddictive Behaviors, Vol. 33, No. 2Addictive Behaviors, Vol. 33, No. 4Biological Psychiatry, Vol. 63, No. 11Brain Research Bulletin, Vol. 77, No. 1European Journal of Pharmacology, Vol. 600, No. 1-3European Neuropsychopharmacology, Vol. 18European Neuropsychopharmacology, Vol. 18Journal of Health Economics, Vol. 27, No. 5Neuroscience, Vol. 154, No. 3Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, No. 4Psychological Medicine, Vol. 38, No. 9The International Journal of Neuropsychopharmacology, Vol. 11, No. 01Neuropsychopharmacology, Vol. 33, No. 6Advances in Dual Diagnosis, Vol. 1, No. 1Physiological Reviews, Vol. 88, No. 2Annals of the New York Academy of Sciences, Vol. 1141, No. 1Drug Safety, Vol. 31, No. 8Clinical Schizophrenia & Related Psychoses, Vol. 2, No. 1Health Behaviors among Individuals with Schizophrenia and Depression1 July 2016 | Journal of Health Psychology, Vol. 12, No. 4Clozapine-Resistant Psychosis, Smoking, and Caffeine: Managing the Neglected Effects of Substances That Our Patients Consume Every DayAmerican Journal of Therapeutics, Vol. 14, No. 3Depression and cardiovascular comorbidity1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 9, No. 1Serious mental illness and physical health problems: A discussion paperInternational Journal of Nursing Studies, Vol. 44, No. 3Successful Tobacco Dependence Treatment in SchizophreniaJill M. Williams, M.D.Jonathan Foulds, Ph.D.1 February 2007 | American Journal of Psychiatry, Vol. 164, No. 2Human Psychopharmacology: Clinical and Experimental, Vol. 22, No. 7Cellular and Molecular Neurobiology, Vol. 27, No. 5Neuropsychology Review, Vol. 17, No. 3, Vol. 78American Journal of Preventive Medicine, Vol. 33, No. 6Biochemical Pharmacology, Vol. 74, No. 8Biochemical Pharmacology, Vol. 74, No. 8Comprehensive Psychiatry, Vol. 48, No. 3Comprehensive Psychiatry, Vol. 48, No. 6European Neuropsychopharmacology, Vol. 17Neuroscience, Vol. 144, No. 4Pharmacology Biochemistry and Behavior, Vol. 86, No. 3Psychiatry Research, Vol. 152, No. 2-3Schizophrenia Research, Vol. 91, No. 1-3Schizophrenia Research, Vol. 97, No. 1-3Experimental and Clinical Psychopharmacology, Vol. 15, No. 1Neuropsychopharmacology, Vol. 32, No. 1Journal of Psychoactive Drugs, Vol. 39, No. 4Journal of Dual Diagnosis, Vol. 3, No. 2Journal of Dual Diagnosis, Vol. 3, No. 3-4Journal of Dual Diagnosis, Vol. 3, No. 3-4Journal of Dual Diagnosis, Vol. 3, No. 3-4Journal of Dual Diagnosis, Vol. 3, No. 3-4Chest, Vol. 132, No. 1Jornal Brasileiro de Psiquiatria, Vol. 56, No. 2Revista de Psiquiatria do Rio Grande do Sul, Vol. 29, No. 3Jornal Brasileiro de Pneumologia, Vol. 33, No. 5American Journal of Health-System Pharmacy, Vol. 64, No. 8Tabagisme et schizophrénie : impacts sur la maladie et son traitement24 January 2008 | Drogues, santé et société, Vol. 6, No. 1Améliorer les symptômes et le tabagisme chez les personnes souffrant de schizophrénie : un manque d'effet synergique du médicament antipsychotique25 March 2008 | Santé mentale au Québec, Vol. 32, No. 2A Randomized Controlled Trial of a Smoking Cessation Intervention Among People With a Psychotic DisorderAmanda Baker, Ph.D.Robyn Richmond, Ph.D.Melanie Haile, M.Psych.(Appl.)Terry J. Lewin, B.Com.(Psych.) Hons.Vaughan J. Carr, M.D., F.R.A.N.Z.C.P.Rachel L. Taylor, M.Clin.Psych.Sylvia Jansons, R.N.Kay Wilhelm, M.D., F.R.A.N.Z.C.P.1 November 2006 | American Journal of Psychiatry, Vol. 163, No. 11Tabaquismo en la esquizofrenia a largo plazo12 May 2020 | European psychiatry (Ed. Española), Vol. 13, No. 8Treatment for Cigarette Smoking Among Depressed Mental Health Outpatients: A Randomized Clinical TrialAmerican Journal of Public Health, Vol. 96, No. 10Increased Suicidal Risk Among Smoking Schizophrenia PatientsClinical Neuropharmacology, Vol. 29, No. 4Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans20 September 2005 | Journal of Psychopharmacology, Vol. 20, No. 4Cigarette smoking in long-term schizophrenia16 April 2020 | European Psychiatry, Vol. 21, No. 4Smoking and Schizophrenia: Is Symptom Profile Related to Smoking and which Antipsychotic Medication is of Benefit in Reducing Cigarette use?17 November 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 40, No. 6-7Directrices para dejar de fumar: recomendaciones científico-estadísticas de la Agencia Francesa de Seguridad de los Productos Sanitarios12 May 2020 | European psychiatry (Ed. Española), Vol. 13, No. 3Cochrane Database of Systematic Reviews, Vol. 98Psychopharmacology, Vol. 184, No. 3-4Psychopharmacology, Vol. 184, No. 3-4Community Mental Health Journal, Vol. 42, No. 2Journal of Psychopathology and Behavioral Assessment, Vol. 28, No. 4Annales Médico-psychologiques, revue psychiatrique, Vol. 164, No. 2Behavioural Brain Research, Vol. 167, No. 1Biological Psychiatry, Vol. 59, No. 8Biological Psychiatry, Vol. 60, No. 6Brain Research, Vol. 1073-1074Journal of Physiology-Paris, Vol. 99, No. 2-3Neuroscience Letters, Vol. 404, No. 1-2NeuroImage, Vol. 29, No. 2Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 30, No. 2Psychiatry Research, Vol. 144, No. 2-3Schizophrenia Research, Vol. 83, No. 2-3Schizophrenia Research, Vol. 87, No. 1-3Schizophrenia Research, Vol. 88, No. 1-3British Journal of Cancer, Vol. 95, No. 7Smoking cessation and depression: current knowledge and future directions29 May 2009 | Drug and Alcohol Review, Vol. 25, No. 1Clinical Psychology: Science and Practice, Vol. 10, No. 1Journal of Dual Diagnosis, Vol. 2, No. 4Journal of Dual Diagnosis, Vol. 2, No. 4Expert Opinion on Drug Metabolism & Toxicology, Vol. 2, No. 4Smoking Bans in Psychiatric Inpatient Settings? A Review of the Research26 June 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 39, No. 10The possible contribution of neuronal nicotinic acetylcholine receptors in depression1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 7, No. 3Uso del tabaco en la esquizofrenia: un estudio de las concentraciones de cotinina en la saliva de pacientes y controles12 May 2020 | European psychiatry (Ed. Española), Vol. 12, No. 6Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency16 April 2020 | European Psychiatry, Vol. 20, No. 5-6Smoking and young people's mental healthCurrent Opinion in Psychiatry, Vol. 18, No. 4Prevalence and Impact of Medical Disorders in Hospitalized Psychiatric Patients with Comorbid Substance Use DisordersAddictive Disorders & Their Treatment, Vol. 4, No. 2Diminished Suppression of the P50 Auditory Evoked Potential in Bipolar Disorder Subjects With a History of PsychosisAnn Olincy, M.D., and Laura Martin, M.D.1 January 2005 | American Journal of Psychiatry, Vol. 162, No. 1European Eating Disorders Review, Vol. 13, No. 6Der Nervenarzt, Vol. 76, No. 3Molecular Imaging and Biology, Vol. 7, No. 6Cognitive and Behavioral Practice, Vol. 12, No. 3Brain Research Reviews, Vol. 49, No. 3Clinical Psychology Review, Vol. 25, No. 6European Neuropsychopharmacology, Vol. 15, No. 5Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls16 April 2020 | European Psychiatry, Vol. 20, No. 1General Hospital Psychiatry, Vol. 27, No. 5Journal of Anxiety Disorders, Vol. 19, No. 6Neuroscience & Biobehavioral Reviews, Vol. 29, No. 6Neurotoxicology and Teratology, Vol. 27, No. 3Pharmacology Biochemistry and Behavior, Vol. 82, No. 2Pharmacology Biochemistry and Behavior, Vol. 82, No. 3Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, No. 1Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, No. 4Psychiatry Research, Vol. 134, No. 3Respiratory Medicine, Vol. 99, No. 10Schizophrenia Research, Vol. 75, No. 2-3Schizophrenia Research, Vol. 76, No. 2-3Schizophrenia Research, Vol. 79, No. 1Neuropsychopharmacology, Vol. 30, No. 4Neuropsychopharmacology, Vol. 30, No. 3Neuropsychopharmacology, Vol. 30, No. 6American Journal on Addictions, Vol. 14, No. 5American Journal on Addictions, Vol. 14, No. 2International Journal of Psychiatry in Clinical Practice, Vol. 9, No. 2Nicotine & Tobacco Research, Vol. 7, No. 3Nicotine & Tobacco Research, Vol. 7, No. 5Journal of Psychiatric and Mental Health Nursing, Vol. 12, No. 6Journal of Dual Diagnosis, Vol. 1, No. 2Journal of Evidence-Based Social Work, Vol. 2, No. 1-2Occurrence of Cancer Among People With Mental Health Claims in an Insured PopulationPsychosomatic Medicine, Vol. 66, No. 5Higher Rates of Cigarette Smoking in Male Adolescents Before the Onset of Schizophrenia: A Historical-Prospective Cohort StudyMark Weiser, M.D., Abraham Reichenberg, Ph.D., Itamar Grotto, M.D., Ross Yasvitzky, B.Sc., Jonathan Rabinowitz, Ph.D., Gad Lubin, M.D., Daniella Nahon, M.A., Haim Y. Knobler, M.D., and Michael Davidson, M.D.1 July 2004 | American Journal of Psychiatry, Vol. 161, No. 7Managing the Clinical Consequences of Psychiatric Illness and Antipsychotic Treatment: A Discussion of Obesity, Diabetes, and Hyperprolactinemia25 November 2016 | Journal of the American Psychiatric Nurses Association, Vol. 10, No. 3_supplRisk for Cancer in Parents of Patients With SchizophreniaSusanne Oksbjerg Dalton, M.D., Ph.D., Thomas Munk Laursen,